ciprofloxacin has been researched along with Vascular Diseases in 2 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henno, P | 1 |
| Boitiaux, JF | 1 |
| Douvry, B | 1 |
| Cazes, A | 1 |
| Lévy, M | 1 |
| Devillier, P | 1 |
| Delclaux, C | 1 |
| Israël-Biet, D | 1 |
| García-Rosario, LN | 1 |
| Ramírez-Ronda, CH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Assessment of a Peripheral Endothelial Dysfunction in COPD (Chronic Obstructive Pulmonary Disease)[NCT02593357] | 137 participants (Actual) | Interventional | 2012-12-17 | Completed | |||
| Peripheral Endothelial Function in Asthmatic Patients[NCT02593344] | 113 participants (Actual) | Interventional | 2012-12-13 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ciprofloxacin and Vascular Diseases
| Article | Year |
|---|---|
[The use of ciprofloxacin in patients with osteomyelitis associated with vascular insufficiency].
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Humans; Leg; Osteomyelitis; Vascul | 1990 |
1 other study available for ciprofloxacin and Vascular Diseases
| Article | Year |
|---|---|
Tobacco-associated pulmonary vascular dysfunction in smokers: role of the ET-1 pathway.
Topics: Acetylcholine; Adult; Aged; Antihypertensive Agents; Blotting, Western; Ciprofloxacin; Endothelin A | 2011 |
Tobacco-associated pulmonary vascular dysfunction in smokers: role of the ET-1 pathway.
Topics: Acetylcholine; Adult; Aged; Antihypertensive Agents; Blotting, Western; Ciprofloxacin; Endothelin A | 2011 |
Tobacco-associated pulmonary vascular dysfunction in smokers: role of the ET-1 pathway.
Topics: Acetylcholine; Adult; Aged; Antihypertensive Agents; Blotting, Western; Ciprofloxacin; Endothelin A | 2011 |
Tobacco-associated pulmonary vascular dysfunction in smokers: role of the ET-1 pathway.
Topics: Acetylcholine; Adult; Aged; Antihypertensive Agents; Blotting, Western; Ciprofloxacin; Endothelin A | 2011 |